Jun 30, 2025
5 minutes read
Clinicians are increasingly exploring roles outside of direct clinical practice and in Medical Affairs, reflecting the growing recognition of the value their clinical expertise brings to the pharmaceutical industry. Medical Affairs has evolved into a strategic function, serving as a bridge between research and development and the broader healthcare community. Within this space, MSLs can leverage their patient-care experience to communicate complex scientific information in a clear, evidence-based manner. MSLs are responsible for delivering scientific communications to healthcare professionals and other stakeholders that are factually accurate and compliant with industry standards. The credibility and clinical understanding of clinician-MSLs enable them to build trust with key opinion leaders and tailor data to real-world clinical practice.
Transitioning from clinical practice to the pharmaceutical industry can be both challenging and rewarding. Many physicians find value in the opportunity to contribute to the development of new therapies and positively impact the lives of thousands of patients on a broader scale. Medical Affairs professionals often engage directly with regulators, payors, and prescribers, which is very similar to clinical practice interactions. Their medical training and real-world experience enable them to effectively address complex clinical questions, support informed decision-making, and influence the adoption of new therapies across healthcare systems.
Clinicians naturally excel at interpreting clinical data and understanding patient pathways. Physicians analyze clinical data to inform their diagnoses. Pharmacists can speak to a physician with clinical jargon in one minute and then interpret that jargon to layman's terms to a patient at the counter in the next minute. These skills translate into enhanced scientific communication in Medical Affairs. For example, a recent position statement emphasizes that MSLs translate research findings “from the bench to the bedside,” helping healthcare providers understand and apply new therapeutic advances. In practice, MSLs engage KOLs, investigators, and other external experts in peer-to-peer exchanges. Medical affairs professionals with clinical backgrounds engage with KOLs on advisory boards to discuss current practices, unmet needs, study designs, and treatment guidelines. These interactions can yield valuable insights into patient care and clinical gaps, which MSLs relay back to R&D and cross-functional teams. The credibility gained from practicing medicine helps clinician-MSLs quickly build rapport, giving them an advantage in establishing scientific credibility with their colleagues.
A successful Medical Affairs professional also needs a solid grasp of the regulatory environment and evidence generation. In recent years, real-world data (RWD) and evidence (RWE) have become critical to regulatory and market-access decisions. Indeed, industry experts note that RWD/RWE’s role in healthcare decision-making has expanded globally, prompting pharma to build both global and local RWE capabilities. Regulatory agencies like the FDA and EMA now issue guidance on using RWD/RWE to support label expansions and other submissions. As a result, Medical Affairs teams often contribute to integrated evidence plans that span pre-approval trials through post-marketing studies. They may help design pivotal trials by suggesting relevant endpoints or patient subgroups, and they often “own” Phase IV and outcomes research in areas not fully explored during initial development.
Clinicians moving into Medical Affairs may not immediately realize that their day-to-day experiences in patient care often mirror the RWE that Pharma increasingly relies on. Their familiarity with treatment patterns, patient outcomes, comorbidities, and adherence challenges offers valuable insight into how therapies perform outside of controlled clinical trials. This real-world perspective is not only translatable but essential in shaping strategies that bridge science with practice.
Clinicians interested in medical affairs commonly explore the MSL role. Successful MSLs combine clinical expertise with broader business and communication skills. Key competencies include:
These competencies can be developed through targeted learning and experience. Clinicians can take courses or obtain certifications in medical affairs, pharmacoeconomics, or regulatory affairs. Participating in research projects, writing publications, or joining advisory boards demonstrates these skills and gives exposure to the multiple perspectives and benefits of these projects.
Clinicians aiming for senior Medical Affairs roles should adopt a leadership mindset early. This means taking the initiative on high-impact projects and understanding how Medical Affairs advances patient care and business goals. Future MSL leaders will need capabilities in communication, business leadership, and data analytics. In practice, this could involve organizing a scientific advisory board meeting, mentoring junior colleagues in evidence evaluation, or leading a patient engagement initiative.
Continuous learning is crucial. The field is rapidly evolving with trends like digital health tools, personalized medicine, and patient-centric approaches. Clinicians should seek training in these areas; for instance, board certifications for MSLs can formalize industry knowledge and best practices. Experience in health economics or digital communication (through workshops or self-study) can also keep them at the forefront.
Mentorship and networking are vital during the transition. Connecting with experienced MSLs or pharma physicians provides insider perspectives on the role. Some companies have formal mentorship programs; clinicians should also seek external mentors (for example, through pharmaceutical medicine societies or local industry networks) who understand how to position clinical skills in an industry context. Informational interviews with Medical Affairs professionals can clarify job expectations and career paths.
Building a professional network is equally important. Joining relevant associations or LinkedIn groups and attending industry conferences often uncovers job leads. Clinicians can engage in cross-disciplinary projects (such as serving as a clinical liaison in a research study) to gain informal experience. Asking mentors or contacts for feedback on one’s resume and interview skills can also be invaluable. Over time, these relationships not only help in landing an initial Medical Affairs role but also provide guidance and advocacy for advancement.
Clinicians interested in Medical Affairs can take deliberate steps to prepare for the move:
By developing these areas, clinicians can enter Medical Affairs not just as newcomers, but as credible, strategic contributors poised for leadership roles.
Clinicians bring unique strengths, deep medical knowledge, patient-centered insight, and credibility with peers, which are increasingly valued in the industry. By embracing new skills in regulatory strategy, cross-functional collaboration, and data analytics, clinicians can effectively bridge the gap between the bedside and the boardroom. Cultivating leadership abilities and seeking mentorship will further enhance their impact. In the end, clinician-scientists who move into Medical Affairs play a pivotal role in advancing patient care through science-driven dialogue.